Samyong Kim
Overview
Explore the profile of Samyong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoo S, Yun Y, Kim K, Lee J, Park J, Choi Y, et al.
Qual Life Res
. 2019 Feb;
28(6):1693.
PMID: 30790153
In the original publication of the article, the incorrect grant number HC13C1391 was published in the acknowledgement section. The correct grant number is HC15C1391.
2.
Yoo S, Yun Y, Kim K, Lee J, Park J, Choi Y, et al.
Qual Life Res
. 2018 Feb;
27(6):1571-1581.
PMID: 29478132
Purpose: The objective of this study was to investigate the impact of caregivers' role preference in decision making on conflicts and psychiatric distresses. Methods: The responses of 406 caregivers of...
3.
Jung M, Ryu M, Oh D, Kang M, Zang D, Hwang I, et al.
Gastric Cancer
. 2018 Feb;
21(5):819-830.
PMID: 29427038
Background: Ramucirumab improves survival in gastric cancer patients. The efficacy and safety of ramucirumab outside of a clinical trial were evaluated using an expanded access program (EAP). Methods: Advanced gastric...
4.
Byun J, Ahn J, Kim S, Kang J, Zang D, Kang S, et al.
Korean J Intern Med
. 2017 Nov;
34(1):165-177.
PMID: 29172407
Background/aims: Colorectal cancer is associated with different anatomical, biological, and clinical characteristics. We determined the impact of the primary tumor location in patients with metastatic colorectal cancer (mCRC). Methods: Demographic...
5.
Kim C, Choi Y, Moon J, Kim D, Lee S, Lee H, et al.
Korean J Intern Med
. 2017 Nov;
34(2):383-389.
PMID: 29172399
Background/aims: Few studies have addressed whether there are differences in clinical efficacy between intravenous methylprednisolone (methyl-Pd) and intravenous immunoglobulin (IVIg) use. Methods: We retrospectively compared platelet responses and toxicities associated...
6.
Moon J, Baek S, Ryu H, Choi Y, Song I, Yun H, et al.
Medicine (Baltimore)
. 2017 Jan;
96(4):e5942.
PMID: 28121937
We retrospectively reviewed outcomes of treatment with VIP (combination of etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma (STS).We analyzed the medical records of patients with...
7.
Choi Y, Park S, Song E, Cho S, Park M, Park K, et al.
Head Neck
. 2016 Apr;
38(8):1271-7.
PMID: 27043228
Background: In T4a laryngeal cancer with thyroid cartilage invasion, no optimal frontline treatment has yet been defined in controlled trials. Methods: We reviewed data from 89 patients with T4a laryngeal...
8.
Kim H, Lee S, Kim D, Moon J, Choi Y, Song I, et al.
Blood Res
. 2016 Jan;
50(4):218-26.
PMID: 26770949
Background: The C-X-C chemokine receptor 7 (CXCR7) has been shown to be a decoy receptor for CXCR4 in certain cell types. We investigated the expression status and functional roles of...
9.
Ryu H, Choi Y, Song I, Yun H, Jo D, Kim S, et al.
Oncol Lett
. 2016 Jan;
10(5):3310-3314.
PMID: 26722331
Endometrial stromal sarcoma (ESS) occurs rarely and accounts for only 0.2% of all uterine malignancies. ESS usually expresses estrogen and progesterone receptors, and is regarded as hormone-sensitive. Due to the...
10.
Yun H, Ryu H, Choi Y, Song I, Jo D, Kim S, et al.
Oncol Lett
. 2015 Dec;
10(3):1227-1232.
PMID: 26622655
Chemokine receptors are key mediators of normal physiology and numerous pathological conditions, including inflammation and cancer. This receptor family is an emerging target for anticancer drug development. C-X-C motif receptor...